ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs MXN
16.6116
-0.06%
Brent Oil
81.71
-0.89%
Bitcoin
70,112.56
-0.03%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Amylin Pharmaceuticals, Inc. (MM) (AMLN)

  7. Amylin Pharmaceuticals, Inc. (MM) (AMLN) Noticias

AMLN

Amylin Pharmaceuticals, Inc. (MM) (AMLN)

Amylin Pharmaceuticals, Inc. (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AMLN
FechaHoraFuenteTítuloSímboloCompañía
09/08/201207:24Dow Jones NewsAstraZeneca: Bristol-Myers Squibb Completes Purchase of AmylinNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
08/08/201215:11Edgar (US Regulatory)(25-NSE)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
08/08/201208:19Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
08/08/201207:40Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
03/08/201215:26Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201217:03Dow Jones News2nd UPDATE: Bristol-Myers Executive Charged With Insider TradingNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201213:00Dow Jones NewsUPDATE: Bristol-Myers Executive Charged With Insider TradingNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201211:30Dow Jones NewsBristol-Myers Executive Charged With Insider TradingNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201211:17Dow Jones NewsU.S. Charges Bristol-Myers Executive With Insider TradingNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201210:07Dow Jones NewsBristol-Myers Pension Executive Robert Ramnarine Arrested for Alleged Insider Trading -BloombergNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
01/08/201206:30Business WireBristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, ...NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
31/07/201212:32ZacksSolid Quarter at ALKS, View Backed - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
30/07/201215:23Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
26/07/201219:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
26/07/201209:24Dow Jones NewsEvercore 2nd-Quarter Profit Climbs 19% On Higher Investment Banking RevenueNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
25/07/201207:20Dow Jones NewsBristol-Myers Profit Falls 28%NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
25/07/201207:00Dow Jones NewsBristol-Myers 2nd-Quarter Profit Falls 28% on Drug-Patent ExpirationsNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
25/07/201204:39ZacksGeneric Plavix Hurts Bristol-Myers - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
23/07/201208:30ZacksEarnings Preview: Bristol-Myers - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
17/07/201213:10ZacksTPG to Acquire Par Pharma for $1.9B - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
12/07/201214:05Dow Jones NewsUPDATE: Icahn Appeals to Nonmanagement Directors at Forest LabsNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
11/07/201217:10Business WireThe Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin...NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
11/07/201212:03ZacksBristol-Myers/AMLN Deal Progresses - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
10/07/201211:01PR Newswire (US)Block & Leviton LLP Investigates Amylin Pharmaceuticals, Inc. for Possible Breaches of Fiduciary Duties in Connection with It...NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
10/07/201207:06Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
10/07/201206:30Business WireBristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
10/07/201204:15ZacksAlkermes Upped to Outperform - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
09/07/201211:51PR Newswire (US)Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc.NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
07/07/201208:00Business WireLaw Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
06/07/201207:53Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:AMLN

Su Consulta Reciente

NYSE
DIS
Walt Disney
NASDAQ
AMZN
Amazon.com
COIN
ETHUSD
Ethereum
NYSE
XOM
Exxon Mobil
SPI
SP500
S&P 500
CCOM
OILBRENT
Brent Oil
NYSE
CVX
Chevron
NYSE
KO
Coca Cola
AMEX
XLF
Financial Select Sector
CCOM
US30
US 30
NASDAQ
NVDA
NVIDIA
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
JPM
JP Morgan Chase
COIN
BTCUSD
Bitcoin
NYSE
BAC
Bank of America
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados